Prominent Runners: EnteroMedics Inc. (NASDAQ:ETRM), Fifth Third Bancorp (NASDAQ:FITB)

90

EnteroMedics Inc. (NASDAQ:ETRM)

The company announced its last quarter financial performance results on 11/07/2016. EnteroMedics Inc. (NASDAQ:ETRM) belongs to Medical sector that declined -13.26% in value when last trading session closed at $0.05. The company has a market capitalization of $3.72 Million. The company’s stock has a Return on Assets (ROA) of 0 percent, a Return on Equity (ROE) of 0 percent and Return on Investment (ROI) of -568.7 percent. The company reached its 52-Week high of $3 on Nov 19, 2015 and 52-Week low of $0.05 on Nov 15, 2016.

Earnings per share (ttm) for EnteroMedics Inc. (NASDAQ:ETRM) according to Finviz Data is $-2.98.

This company was Downgrade by ROTH Capital on 9-Jun-16  to Neutral.

The 2 analysts offering 12-month price forecasts for EnteroMedics Inc have a median target of 1.10, with a high estimate of 2.00 and a low estimate of 0.20. The median estimate represents a +1,975.47% increase from the last price of 0.05.

Financial History for EnteroMedics Inc. (NASDAQ:ETRM):

Following Earnings result, share price were DOWN 12 times out of last 26 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 41% percent of times. It has met expectations  4  times and missed earnings  3  times.

The consensus recommendation for EnteroMedics Inc. (NASDAQ:ETRM) is 2. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 2. In comparison, the consensus recommendation 60 days ago was at 2, and 90 days ago was at 2 respectively.

Future Expectations for EnteroMedics Inc. (NASDAQ:ETRM):

When the current quarter ends, Wall Street expects EnteroMedics Inc. to have earnings per share of $-0.44.

Revenue is expected to range from 300 Million to 450 Million with an average of 380 Million.

Company Profile:

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Fifth Third Bancorp (NASDAQ:FITB):

Fifth Third Bancorp (NASDAQ:FITB) belongs to Finance sector closed its last session with a gain of 1.58 percent and closed its previous trading session at $25.67. According to Finviz reported data, the stock currently has Earnings per Share (EPS) (ttm) of $2.24. The company has the Market capitalization of $18.75 Billion. The company’s stock has a Return on Assets (ROA) of 1.2 percent, a Return on Equity (ROE) of 11.5 percent and Return on Investment (ROI) of 8.2 percent. The company reached its 52-Week high of $25.68 on Nov 15, 2016 and 52-Week low of $13.84 on Feb 11, 2016.

The growth estimate for Fifth Third Bancorp (NASDAQ:FITB) for the current quarter is -45.6 percent. The projected growth estimate for the next quarter is -5 percent. The company’s stock has grown by 1.44 percent in the past 5 years. For the next 5 years, the company is expected to grow by 3.15 percent.

This company was Downgrade by Nomura on 10-Oct-16 to Reduce.

The 27 analysts offering 12-month price forecasts for Fifth Third Bancorp have a median target of 22.00, with a high estimate of 24.00 and a low estimate of 16.00. The median estimate represents a -14.30% decrease from the last price of 25.67.

Financial History for Fifth Third Bancorp (NASDAQ:FITB):

Following Earnings result, share price were DOWN 14 times out of last 27 Qtrs. In the last 27 earnings reports, the company has topped earnings-per-share estimates 50% percent of times. It has met expectations  5  times and missed earnings  1 times.

The consensus recommendation for Fifth Third Bancorp (NASDAQ:FITB) is 2.8. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation 30 days ago for this company stood at 2.85. In comparison, the consensus recommendation 60 days ago was at 2.54, and 90 days ago was at 2.54 respectively.

Future Expectations for Fifth Third Bancorp (NASDAQ:FITB):

When the current quarter ends, Wall Street expects Fifth Third Bancorp to have earnings per share of $0.43.

Revenue is expected to range from 1.51 Billion to 1.56 Billion with an average of 1.53 Billion.

Company Profile:

Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through four segments: Commercial Banking, Branch Banking, Consumer Lending, and Investment Advisors. The Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. The Branch Banking segment provides deposit and loan products to individuals and small businesses. This segment offers checking and savings accounts, home equity loans and lines of credit, credit cards, and loans for automobiles and personal financing needs. The Consumer Lending segment engages in direct lending activities that include origination, retention, and servicing of residential mortgage and home equity loans or lines of credit; and indirect lending activities, including loans to consumers through correspondent lenders and automobile dealers. The Investment Advisors segment provides various investment alternatives for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients; and broker dealer services to the institutional marketplace. This segment also provides asset management services; holistic strategies to affluent clients in wealth planning, investing, insurance, and wealth protection; and advisory services for institutional clients comprising states and municipalities. As of December 31, 2015, the company operated 1,254 full-service banking centers, including 95 Bank Mart locations, as well as 2,593 automated teller machines in 12 states throughout the Midwestern and Southeastern regions of the United States. Fifth Third Bancorp was founded in 1862 and is headquartered in Cincinnati, Ohio.